Počet záznamů: 1  

MicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma

  1. 1.
    SYSNO ASEP0465816
    Druh ASEPJ - Článek v odborném periodiku
    Zařazení RIVJ - Článek v odborném periodiku
    Poddruh JČlánek ve WOS
    NázevMicroRNA-126 induces autophagy by altering cell metabolism in malignant mesothelioma
    Tvůrce(i) Tomasetti, M. (IT)
    Monaco, F. (IT)
    Manzella, N. (IT)
    Rohlena, Jakub (BTO-N) RID, ORCID
    Rohlenová, Kateřina (BTO-N) ORCID, RID
    Staffolani, S. (IT)
    Gaetani, S. (IT)
    Ciarapica, V. (IT)
    Amati, M. (IT)
    Bracci, M. (IT)
    Valentino, M. (IT)
    Goodwin, J. (IT)
    Nguyen, M. (AU)
    Truksa, Jaroslav (BTO-N) RID, ORCID
    Sobol, Margaryta (UMG-J) RID
    Hozák, Pavel (UMG-J) RID, ORCID
    Dong, L.F. (AU)
    Santarelli, L. (IT)
    Neužil, Jiří (BTO-N) RID
    Celkový počet autorů19
    Zdroj.dok.OncoTarget. - : Impact Journals LLC - ISSN 1949-2553
    Roč. 7, č. 24 (2016), s. 36338-36352
    Poč.str.15 s.
    Jazyk dok.eng - angličtina
    Země vyd.US - Spojené státy americké
    Klíč. slovapyruvate-dehydrogenase kinase ; mir-126 ; angiogenesis ; tumor suppression
    Vědní obor RIVEB - Genetika a molekulární biologie
    CEPGAP301/10/1937 GA ČR - Grantová agentura ČR
    LM2015062 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    TE01020118 GA TA ČR - Technologická agentura ČR
    GA16-22823S GA ČR - Grantová agentura ČR
    ED1.1.00/02.0109 GA MŠMT - Ministerstvo školství, mládeže a tělovýchovy
    Institucionální podporaBTO-N - RVO:86652036 ; UMG-J - RVO:68378050
    UT WOS000377756800066
    DOI10.18632/oncotarget.8916
    AnotaceAutophagy favors both cell survival and cancer suppression, and increasing evidence reveals that microRNAs (MIRs) regulate autophagy. Previously we reported that MIR126 is downregulated in malignant mesothelioma (MM). Therefore, we investigated the role of MIR126 in the regulation of cell metabolism and autophagy in MM models. We report that MIR126 induces autophagic flux in MM cells by downregulating insulin receptor substrate-1 (IRS1) and disrupting the IRS1 signaling pathway. This was specific to MM cells, and was not observed in non-malignant cells of mesothelial origin or in MM cells expressing MIR126-insensitive IRS1 transcript. The MIR126 effect on autophagy in MM cells was recapitulated by IRS1 silencing, and antagonized by IRS1 overexpression or antisense MIR126 treatment. The MIR126-induced loss of IRS1 suppressed glucose uptake, leading to energy deprivation and AMPK-dependent phosphorylation of ULK1. In addition, MIR126 stimulated lipid droplet accumulation in a hypoxia-inducible factor-1 alpha (HIF1 alpha)-dependent manner. MIR126 also reduced pyruvate dehydrogenase kinase (PDK) and acetyl-CoA-citrate lyase (ACL) expression, leading to the accumulation of cytosolic citrate and paradoxical inhibition of pyruvate dehydrogenase (PDH) activity. Simultaneous pharmacological and genetic intervention with PDK and ACL activity phenocopied the effects of MIR126. This suggests that in MM MIR126 initiates a metabolic program leading to high autophagic flux and HIF1 alpha stabilization, incompatible with tumor progression of MM. Consistently, MIR126-expressing MM cells injected into immunocompromised mice failed to progress beyond the initial stage of tumor formation, showing that increased autophagy has a protective role in MM.
    PracovištěBiotechnologický ústav
    KontaktMonika Kopřivová, Monika.Koprivova@ibt.cas.cz, Tel.: 325 873 700
    Rok sběru2017
Počet záznamů: 1  

  Tyto stránky využívají soubory cookies, které usnadňují jejich prohlížení. Další informace o tom jak používáme cookies.